Acta Pharmaciae Indonesia: Acta Pharm Indo will change from a conventional publication model to a continuous publication model in 2022. It allows the immediate publication of an article as soon as it is ready for publication and does not have to wait until a particular issue of the journal is completed.

To maintain the quality and standards of the journal, the article publishing charge (APC) will be applied to volume 10 (2022) and the volumes following after. 

Read More Read more about Important changes in 2022

We announced that Acta Pharmaciae Indonesia: Acta Pharm Indo has accredited SINTA 4 by Surat Keputusan Menteri Riset dan Teknologi Kepala Badan Riset dan Inovasi Nasional Nomor 148/M/KPT/2020, tanggal 3 Agustus 2020. This accreditation applied from vol 6(1): 2018 to vol 10(2): 2022. Read More Read more about ACCREDITATION OF ACTA PHARMACIAE INDONESIA: Acta Pharm Indo

Read More Read more about ACCREDITATION CERTIFICATE